Q1 2017 Holdings
Filed 2017-05-15 | 33 holdings | $395.6K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-05-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Assembly Biosciences Inc | COM | 045396108 | $75.0K | 2,943,164 | 19.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM | 46333X108 | $49.6K | 2,905,515 | 12.5% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $47.5K | 551,041 | 12.0% |
| Gilead Sciences IncCall | COM | 375558903 | $34.0K | 500,000 | 8.6% |
| Ascendis Pharma A S(ASND)A | SPONSORED ADR | 04351P101 | $28.7K | 1,025,700 | 7.3% |
| Kura Oncology Inc COM(KURA) | COM | 50127T109 | $23.0K | 2,611,906 | 5.8% |
| Theravance Biopharma Inc | NOTE | 88338TAB0 | $21.4K | $17,000,000 | 0.0% |
| Theravance Biopharma IncA | NOTE | 88339KAA0 | $21.4K | $17,000,000 | 5.4% |
| Aclaris Therapeutics Inc(ACRS)A | COM | 00461U105 | $20.1K | 673,100 | 5.1% |
| Cytomx Therapeutics Inc(CTMX)A | COM | 23284F105 | $13.7K | 794,969 | 3.5% |
| Cascadian Therapeutics Inc | COM | 14740B606 | $12.4K | 3,000,000 | 3.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $11.5K | 2,537,026 | 2.9% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $8.9K | 434,812 | 2.3% |
| Atyr Pharma Inc(LIFEUSD) | COM | 002120103 | $8.0K | 2,292,659 | 2.0% |
| Ovascience Inc | COM | 69014Q101 | $6.6K | 3,512,332 | 1.7% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $5.7K | 258,457 | 1.4% |
| Xencor Inc(XNCR) | COM | 98401F105 | $5.6K | 234,813 | 1.4% |
| Kindred Biosciences Inc | COM | 494577109 | $3.8K | 544,880 | 1.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $3.2K | 264,773 | 0.8% |
| Regulus Therapeutics IncA | COM | 75915K101 | $2.5K | 1,510,000 | 0.6% |
| Regulus Therapeutics Inc | COM | 75915K951 | $2.5K | 1,510,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $2.4K | 874,447 | 0.6% |
| Versartis Inc | COM | 92529L102 | $2.1K | 100,000 | 0.5% |
| Viveve MED Inc | COM | 92852W204 | $1.6K | 250,000 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO)A | COM | 00847X104 | $1.4K | 23,300 | 0.3% |
| Dicerna Pharmaceuticals Inc(DRNAUSD)A | COM | 253031108 | $1.3K | 382,000 | 0.3% |
| Dicerna Pharmaceuticals Inc | COM | 253031908 | $1.3K | 382,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $1.0K | 42,009 | 0.3% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $1.0K | 63,596 | 0.3% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $928 | 17,060 | 0.2% |
| Chemocentryx Inc(CCXIEUR)A | COM | 16383L106 | $859 | 118,000 | 0.2% |
| Chemocentryx Inc | COM | 01683L106 | $859 | 118,000 | 0.0% |
| Syndax Pharmaceuticals Inc COM(SNDX) | COM | 87164F105 | $484 | 35,301 | 0.1% |
| Cascadian Therapeutics IncCall | COM | 14740B906 | $430 | 103,800 | 0.1% |
| Orexigen Therapeutics Inc | COM | 686164302 | $405 | 117,726 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $275 | 10,000 | 0.1% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $108 | 5,025 | 0.0% |